Point72 Hong Kong LTD Invitae Corp Transaction History

Point72 Hong Kong LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $25,201 - $114,468	13,264 Added 55.88%	37,002 $91,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $16,799 - $71,061	7,887 Added 49.76%	23,738 $58,000
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $99,544 - $247,117	15,851 New	15,851 $126,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $52,317 - $102,036	-3,559 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $86,519 - $119,582	3,559 New	3,559 $101,000
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $198,623 - $307,565	-7,613 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $249,173 - $429,081	7,537 Added 9917.11%	7,613 $291,000
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $2,970 - $4,362	76 New	76 $3,000
Q3 2020 Nov 16, 2020	SELL	$28.43 - $44.67 $86,370 - $135,707	-3,038 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $35,574 - $92,021	3,038 New	3,038 $92,000
Q4 2017 Feb 14, 2018	SELL	$7.86 - $9.99 $20,915 - $26,583	-2,661 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.89 - $10.4 $23,656 - $27,674	2,661	2,661 $25,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.